Events

News

Unlocking the Secrets of Autism Diagnosis with AI: A Breakthrough Study

Exciting Sponsorship Programs for NSCLC and Solid Tumor Patients

Guardant Health’s Shield™ Blood Test Approved by FDA

[Bowtie網誌] 傳統癌症指數已過時？了解追蹤癌症治療成效的新指標！

Breakthrough ALS Treatment Approved in Japan: Mecoba

Neurologist Dr. Lawrence Wong recommends that ApoE4 gene testing be performed before starting new Alzheimer's drug treatment to assess the risk of brain edema/brain microbleeding [Reprinted from Sing Tao.com]

AKEEGA™ receives U.S. FDA Approval for BRCA-Induced Metastatic Castration-Resistant Prostate Cancer (mCRPA)

[專題講座] 癌症篩查知識：早發現，早預防

Codex Showcases Innovation at MedFair 2025 with HKSTP

Successful Recruitment Talk at HKUST

Codex will participate in Best of ASCO 2024, Hong Kong

「香港自閉症診斷、治療與管理的全景觀」實體講座

Join Us at the Hong Kong International Medical and Healthcare Fair 2025

[HOY TV Health Focus] Codex was recently invited to introduce our liquid biopsy test for detecting early-stage breast cancer recurrence on the HOY TV Health Focus TV show | Guardant Reveal | Cancer Liquid Biopsy

Codex Annual Oncology Roundtable: Tackling Minimal Residual Disease and Complex Mutations